Zobrazeno 1 - 10
of 30
pro vyhledávání: '"GMT, Geometric mean titer"'
Autor:
Kai Wu, Carole Henry, Charis Palandjian, Sarah O’Connell, Angela Woods, Darin K. Edwards, Anna Hill, Hamilton Bennett, Naveen Nunna, Elisabeth Narayanan, Samantha Falcone, Matthew A. Koch, Andrea Carfi, Robert A. Seder, Diana Lee, Guillaume Stewart-Jones, LingZhi Ma, Barney S. Graham, Angela Choi, Tonya M. Colpitts, Kizzmekia S. Corbett, Adrian B. McDermott, Sayda Elbashir, Julian Quinones, Hardik Jani
Publikováno v:
bioRxiv
Vaccine
Vaccine
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of a global pandemic that has led to more than 2.8 million deaths worldwide. Safe and effective vaccines are now available, including Moderna’s COVID-19 vaccine (mR
Autor:
Eric Destexhe, Sarah Paris-Robidas, Charlotte Dubé, Nathalie Landry, Sonia Trépanier, Iryna Primakova, Brian J. Ward
Publikováno v:
Reproductive Toxicology (Elmsford, N.y.)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection resulting in the coronavirus disease 2019 (COVID-19) has afflicted tens of millions of people in a worldwide pandemic. A recently developed recombinant Plant-Derived Virus-Like Pa
Autor:
Paris Charilaou, Christopher Tricarico, Robert Battat, Ellen J. Scherl, Randy S. Longman, Dana J. Lukin
Publikováno v:
Clinical Gastroenterology and Hepatology
Immunization against the spike protein of SARS-CoV-2 reduces transmission
Autor:
Christine M. Akamine, Hana M. El Sahly
Publikováno v:
Translational Research
The mRNA therapeutics have been studied since the 1970s and the currently available mRNA vaccines against COVID-19 are the culmination of decades of scientific research. The mRNA vaccines BNT162b2 and mRNA-1273 have played a key role in our global re
Autor:
Sven Eric Olsson, Pierre Van Damme, Jaime Alberto Restrepo, Alain Luxembourg, Nancy Gallagher, Daron G. Ferris, Edson D. Moreira, Oliver Bautista, Angels Ulied, Jennifer McCauley, Stanley Block, Julio C. Reina, Punnee Pitisuttithum, Meera Varman
Publikováno v:
Papillomavirus Research, Vol 10, Iss, Pp 100203-(2020)
Papillomavirus Research
Papillomavirus Research
Background The nine-valent human papillomavirus (9vHPV) vaccine protects against infection and disease related to HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58. The pivotal 36-month Phase III immunogenicity study of 9vHPV vaccine in 9- to 15-year-o
Autor:
Joaquín Luna, Eugenio Suarez, Gonzalo Perez, Miguel Cashat, Santos Uscanga, Manuel Plata, Christine Shields, Edson D. Moreira, Francisco Revollo, Edison Natal Fedrizzi, Jaime Alberto Restrepo, Rosires Pereira de Andrade, Alain Luxembourg, Claudia Nossa Dominguez, Michael Ritter, Julio C. Reina, Ana Maria Guevara, Robinson Cabello, Arnaldo Silva, Alejandro Victoria, Erin Moeller, Misoo C. Ellison, Eduardo Lazcano-Ponce, Ángela María Ruiz-Sternberg
Publikováno v:
Papillomavirus Research
International Agency for Research on Cancer, GLOBOCAN 2012: estimated cancer incidence (2012) Mortal. Preval. Worldw., http://globocan.iarc.fr/Pages/fact_sheets_population.aspx, (accessed 12 June 2017)
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Papillomavirus Research, Vol 5, Iss, Pp 63-74 (2018)
International Agency for Research on Cancer, GLOBOCAN 2012: estimated cancer incidence (2012) Mortal. Preval. Worldw., http://globocan.iarc.fr/Pages/fact_sheets_population.aspx, (accessed 12 June 2017)
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Papillomavirus Research, Vol 5, Iss, Pp 63-74 (2018)
Background: A 9-valent human papillomavirus (HPV6/11/16/18/31/33/45/52/58; 9vHPV) vaccine was developed to expand coverage of the previously developed quadrivalent (HPV6/11/16/18; qHPV) vaccine. Methods: Efficacy, immunogenicity, and safety outcomes
Autor:
Wang Yajun, Liu Yongjiang, Yefeng Qiu, Zhang Haijiang, Dunquan Jiang, Mei Yan, Wang Yan, Chen Jianping, Yin Fei, Na Chen
Publikováno v:
Papillomavirus Research
Papillomavirus Research, Vol 3, Iss, Pp 85-90 (2017)
Papillomavirus Research, Vol 3, Iss, Pp 85-90 (2017)
Persistent infection with human papillomavirus (HPV) is a key factor in the development of precancerous lesions and invasive cervical cancer. Prophylactic vaccines to immunize against HPV are an effective approach to reducing HPV related disease burd
Autor:
Paola, Russo, Antonio D, Ligsay, Remigio, Olveda, Seuk Keun, Choi, Deok Ryun, Kim, Ju Yeon, Park, Ju Yeong, Park, Khalid Ali, Syed, Ayan, Dey, Yang Hee, Kim, Sung Hee, Lee, Jayoung, Kim, Yun, Chon, Laura, Digilio, Chan Wha, Kim, Jean-Louis, Excler
Publikováno v:
Vaccine
Highlights • Bridging study demonstrating the equivalence of two variations of Euvichol®. • The 600L thimerosal-free Euvichol® is safe and immunogenic in adults and children. • The scale-up of Euvichol® allows expanding global access to oral
Publikováno v:
Veterinary Immunology and Immunopathology
An enzyme-linked immunospot (ELISPOT) has been developed to detect porcine epidemic diarrhea virus (PEDV)-specific antibody secreting cells (ASC) in gut associated lymphoid tissues (duodenum and ileum lamina propria and mesenteric lymph nodes) and sy
Autor:
S.P Mondal, S.A Naqi
Publikováno v:
Veterinary Immunology and Immunopathology
Chicks hatched with high levels of maternal antibody had excellent protection (>95%) against infectious bronchitis virus (IBV) challenge at 1 day of age, but not at 7 days (